Financials
Financial year 2025
Gross margin
€ 531,961
▲ 93% vs 2024
Profit
Growing€ 231,722
▲ 333% vs 2024
Debts
Normal€ 1.2 million
▲ 17% vs 2024
ACE PHARMACEUTICALS BELGIUM from Sint-Martens-Latem, company number BE0732788379, closed financial year 2025 with a result of € 231,722 after tax. For that financial year ACE PHARMACEUTICALS BELGIUM recorded a gross margin of € 531,961 and equity of € 410,226. Compared with financial year 2024, the result moved from € 53,543 to € 231,722. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 9, 2026.
What happened at ACE PHARMACEUTICALS BELGIUM?
What happened at ACE PHARMACEUTICALS BELGIUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 231,722 (▲ 333% vs 2024). Source: NBB ↗
- New establishment in Braine-le-Château. KBO
- Start of the company according to the CBE. KBO
In short
From € 79,643 profit in 2021 to € 231,722 profit in 2025.
Paid € 135,518 in corporate taxes since 2021.
Best year ever: 2025, with € 231,722 profit.
On average € 532,000 of value added per employee in 2025.
A new publication or filing at ACE PHARMACEUTICALS BELGIUM? We notify you, reason included.
Follow ACE PHARMACEUTICALS BELGIUMNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind ACE PHARMACEUTICALS BELGIUM are Ronald STEENTJES, TLYS SCS, Ronald Feiter CORNELIS and AMBERSTE HOLDING BV. It owns 51% of PANNOC CHEMIE itself.
Directors
According to the 2025 annual accounts
Ronald STEENTJES
Managing director
Ronald Feiter CORNELIS
Director
Director
Establishments
Establishment units
Physical locations of this company
Xavier De Cocklaan 66 box 5
9831 Sint-Martens-Latem
Parc Industriel(W-B) 19
1440 Braine-le-Château
Active since 22 August 2019
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 9 companies are registered at this address.
IMMO LARCIER
€ 57,173 gross margin · 2025
Mc THREE HOLDINGS
€ 1.5 million revenue · 2022
G Projects
€ -780 gross margin · 2025
CMN
€ -1,681 gross margin · 2025
Syndiggit
€ 21,828 gross margin · 2025
+4 more
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
METAREGISTRAR, NL
Website info
Features
Security
Network
Details
- Company number
- 0732.788.379
- VAT number
- BE 0732.788.379
- Registered office
- Xavier De Cocklaan 66 bus 5, 9831 Sint-Martens-Latem
- Names & denominations
- ACE PHARMACEUTICALS BELGIUM
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 22 August 2019
- Peppol
- Active · Active since 10 Nov 2025
- Contact
- ace-pharm.be
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied